Advertisement
Screener

REZOLUTE, INC. (RZLT) Return on Tangible Equity

2.8 / 5 stars · 68/120 Roast Me

Rezolute, Inc. Return Tang Equity

Return on tangible equity is the profit a company earns on the physical and financial capital its shareholders own, leaving out goodwill and other intangible assets, shown as a percentage. It is net income divided by tangible equity, which is shareholder equity minus goodwill and intangibles; the table shows both amounts. Because acquired goodwill is removed, it runs higher than ROE for companies that grew by acquisition, and it has no meaning when goodwill exceeds equity. Goodwill and intangibles are taken at the latest reported date on or before each equity date. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • Rezolute, Inc. return tang equity for the quarter ending 2026-03-31 was -69.74%, a change of 18.66% year-over-year.
  • Rezolute, Inc. return tang equity for the quarter ending 2025-12-31 was -65.80%, a change of 5.62% year-over-year.
  • Rezolute, Inc. return tang equity for the quarter ending 2025-09-30 was -52.45%, a change of 8.65% year-over-year.
  • Rezolute, Inc. return tang equity for the quarter ending 2025-06-30 was -45.90%, a change of 10.68% year-over-year.
  • Rezolute, Inc. return tang equity for fiscal 2025 was -45.90%, a change of 10.68% from fiscal 2024.
  • Rezolute, Inc. return tang equity for fiscal 2024 was -56.58%, a change of -12.00% from fiscal 2023.
  • Rezolute, Inc. return tang equity for fiscal 2023 was -44.58%, a change of -17.11% from fiscal 2022.
  • Rezolute, Inc. return tang equity for fiscal 2022 was -27.47%, a change of 52.62% from fiscal 2021.
Available history
2011-06-30 to 2026-03-31
Data captured

Historical Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2026-03-31-69.74%-$81.49M$116.83M
2025-12-31-65.80%-$84.23M$128M
2025-09-30-52.45%-$77.18M$147.17M
2025-06-30-45.90%-$74.41M$162.13M
2025-03-31-88.41%-$73M$82.57M
2024-12-31-71.43%-$71.13M$99.59M
2024-09-30-61.10%-$69.31M$113.44M
2024-06-30-56.58%-$68.46M$121M
2024-03-31-82.15%-$58.21M$70.86M
2023-12-31-61.96%-$56.83M$91.73M
2023-09-30-54.54%-$56.48M$103.56M
2023-06-30-44.58%-$51.79M$116.17M
2023-03-31-38.08%-$48.48M$127.32M
2022-12-31-31.16%-$44.02M$141.27M
2022-09-30-28.12%-$43.06M$153.09M
2022-06-30-27.47%-$41.06M$149.47M
2022-03-31-73.45%-$38.13M$51.91M
2021-12-31-49.17%-$30.61M$62.27M
2021-09-30-116.51%-$25.12M$21.56M
2021-06-30-80.09%-$20.9M$26.1M
2021-03-31-61.65%-$17.96M$29.13M
2020-12-31-53.79%-$19.3M$35.89M
2020-09-30-430.69%-$18.87M$4.38M
2020-06-30-276.08%-$20.33M$7.37M
2020-03-31-193.04%-$19.93M$10.33M
2019-12-31-236.01%-$34.67M$14.69M
2019-09-30-155.99%-$32.16M$20.62M
2019-06-30-1737.79%-$30.45M$1.75M
2019-03-31-855.70%-$39.79M$4.65M
2018-12-31255.27%-$24.99M-$9.79M
2018-09-30411.96%-$26.54M-$6.44M
2018-06-30753.90%-$29.86M-$3.96M
2018-03-31-4420.80%-$23.56M$532,930.00
2017-12-31-630.66%-$23.98M$3.8M
2017-09-30-296.52%-$23.15M$7.81M
2017-06-30-237.77%-$20.28M$8.53M
2017-03-31-212.28%-$17.96M$8.46M
2016-12-31-205.29%-$16.29M$7.93M
2016-09-30-188.53%-$15.46M$8.2M
2016-06-30-170.25%-$14.94M$8.77M
2016-03-31-1260.91%-$14.1M$1.12M
2015-12-31-359.09%-$13.57M$3.78M
2015-09-30-184.02%-$12.44M$6.76M
2015-06-30-125.50%-$11.36M$9.05M
2015-03-31-106.43%-$10.33M$9.7M
2014-12-31-156.61%-$12.24M$7.82M
2014-09-30-221.67%-$11.13M$5.02M
2014-06-30-151.88%-$9.73M$6.41M
2014-03-31-256.91%-$8.75M$3.41M
2013-12-31186.54%-$8.2M-$4.4M
2013-09-30143.69%-$6.92M-$4.82M
2013-06-30161.74%-$6.73M-$4.16M
2013-03-31146.18%-$5.19M-$3.55M
2012-12-313402.03%-$832,477.00-$24,470.00
2012-09-301998.03%-$302,961.00-$15,163.00
2012-06-30-24.87%$320,495.00-$1.29M
2012-03-31-576233.33%-$207,444.00$36.00
2011-12-316.17%-$54,981.00-$890,704.00
2011-09-30-271.06%-$48,734.00$17,979.00

Annual Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2025-06-30-45.90%-$74.41M$162.13M
2024-06-30-56.58%-$68.46M$121M
2023-06-30-44.58%-$51.79M$116.17M
2022-06-30-27.47%-$41.06M$149.47M
2021-06-30-80.09%-$20.9M$26.1M
2020-06-30-276.08%-$20.33M$7.37M
2019-06-30-1737.79%-$30.45M$1.75M
2018-06-30753.90%-$29.86M-$3.96M
2017-06-30-237.77%-$20.28M$8.53M
2016-06-30-170.25%-$14.94M$8.77M
2015-06-30-125.50%-$11.36M$9.05M
2014-06-30-151.88%-$9.73M$6.41M
2013-06-30161.63%-$6.73M-$4.16M
2012-06-303.82%-$49,287.00-$1.29M
2011-12-3166.26%-$590,215.00-$890,704.00
2011-06-30-165.24%-$41,927.00$25,373.00

Similar stocks

Stock NameCountryMarket CapPE Ratio
Turn Therapeutics Inc. (TTRX)United States$0.397B-25.68
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Vogenx, Inc. (VOGX)United States$0.355B
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
ENANTA PHARMACEUTICALS INC (ENTA)United States$0.349B-6.72
Emergent BioSolutions Inc. (EBS)United States$0.347B-2.43